European Journal of Vascular & Endovascular Surgery
Volume 25, Issue 1 , Pages 40-47, January 2003

Pharmacological induction of HSP27 attenuates intimal hyperplasia in vivo

Departments of 1Surgery and 2Pathology, Education and Research Center, Royal College of Surgeons in Ireland, Beaumont Hospital, Beaumont Rd, Dublin 9, Ireland

Accepted 5 October 2002.

*Please address all correspondence to: E. M. Connolly, Department of Surgery, Education and Research Center, Beaumont Hospital, Beaumont Rd, Dublin 9, Ireland.

Abstract 

Objectives: intimal hyperplasia (IH) is a major cause of re-stenosis post-vascular intervention. Induction of heat shock proteins (HSPs), by thermal pre-conditioning, reduces IH. Our aim was to investigate the effect of the pharmacological HSP inducer herbimycin A on IH in the rat carotid balloon injury model. Materials and Methods: thirty male Sprague–Dawley rats were randomized into three groups. All groups underwent balloon injury to the left carotid artery. Stress proteins were induced 18 h pre-operatively by heat shock or herbimycin A. Two weeks post-operatively, animals were sacrificed and carotid intima/media area ratio (I/M ratio) calculated using computerized planimetry. Neo-intimal proliferation was assessed immunohistochemically with PCNA (proliferating cell nuclear antigen). Western blot and immunohistochemistry for arterial HSP70 and HSP27 were performed. Results: heat stress and herbimycin significantly reduced the I/M ratio (p < 0.05 vs balloon injury alone). Neo-intimal proliferation was significantly reduced in the heat stress and herbimycin groups (p < 0.05 vs balloon injury alone). Heat stress induced arterial HSP70 and HSP27. Herbimycin A increased arterial HSP27. Conclusion: herbimycin A significantly attenuates IH after balloon injury. HSP27 may be the HSP involved in mediating this response. Pharmacological inducers of HSPs may have a therapeutic role to play in preventing re-stenosis post-vascular intervention.

Eur J Vasc Endovasc Surg 25, 40–47 (2003)

Keywords:  Intimal hyperplasia, Heat shock proteins, Herbimycin A

 

 This work was funded by a research grant from the Health Research Board, Dublin, Ireland.

PII: S1078-5884(03)70184-1

doi:10.1053/ejvs.2002.1793

European Journal of Vascular & Endovascular Surgery
Volume 25, Issue 1 , Pages 40-47, January 2003